Literature DB >> 19406247

Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007.

W Jamal1, M Shahin, V O Rotimi.   

Abstract

The susceptibility trends for all anaerobes processed by the Anaerobe Reference Laboratory against various antibiotics were determined by using data for 2557 isolates referred by all government hospitals in Kuwait from 2002 to 2007. MIC were determined for the following anti-anaerobic antibiotics: amoxicillin-clavulanic acid, clindamycin, imipenem, meropenem, metronidazole, penicillin, piperacillin, piperacillin-tazobactam and vancomycin (for Gram-positive anaerobes only), using E-test method. The commonest isolates were Bacteroides fragilis (36.8%), followed by Peptostreptococcus spp. (21.9%), Bacteroides ovatus (15.5%) and Prevotella bivia (12.1%). In addition, Prevotella oralis and other Bacteroides spp. represented 8.5% and 8.1% of total number of isolates, respectively. Resistance rate varied among the antimicrobial agents and the species tested. The beta-lactams, with the exception of penicillin, were the most active drugs. Piperacillin-tazobactam was the only antimicrobial agent to which all the isolates were uniformly susceptible. Imipenem and metronidazole were highly active with resistance rate of only <5% recorded against most isolates. However, 42.8, 55.8 and 9.3% of Clostridium difficile isolates were resistant to imipenem, clindamycin and meropenem, respectively. It is noteworthy that from 2002 to 2007, there was a gradual increase in resistance rates to clindamycin, amoxicillin-clavulanic acid and piperacillin among B. fragilis. Periodic surveillance of antibiotic resistance among the anaerobic bacteria is recommended as a guide to empiric antibiotic use and formulation of guideline for appropriate choice of antimicrobial therapy in anaerobic infections. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406247     DOI: 10.1016/j.anaerobe.2009.04.004

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  7 in total

1.  Prevalence of antimicrobial resistance in Gram-negative clinical isolates from a major secondary hospital in Kuwait: a retrospective descriptive study.

Authors:  Walid Q Alali; Wadha AlFouzan; Rita Dhar
Journal:  Germs       Date:  2021-12-29

2.  Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosis.

Authors:  Laura J Sherrard; Kathryn A Graham; Stef J McGrath; Leanne McIlreavey; Joseph Hatch; Marianne S Muhlebach; Matthew C Wolfgang; Deirdre F Gilpin; J Stuart Elborn; Thamarai Schneiders; Michael M Tunney
Journal:  J Antimicrob Chemother       Date:  2013-05-21       Impact factor: 5.790

Review 3.  Osteomyelitis of a long bone due to Fusobacterium nucleatum and Actinomyces meyeri in an immunocompetent adult: a case report and literature review.

Authors:  Min Ji Lee; Young Eun Ha; Hye Yon Park; Jun Hee Lee; Yoon Jung Lee; Ki Sun Sung; Cheol-In Kang; Doo Ryeon Chung; Jae-Hoon Song; Kyong Ran Peck
Journal:  BMC Infect Dis       Date:  2012-07-20       Impact factor: 3.090

4.  Antimicrobial resistance and prevalence of resistance genes in intestinal Bacteroidales strains.

Authors:  Viviane Nakano; Amanda do Nascimento e Silva; Victor Rafael Castillo Merino; Hannah M Wexler; Mario Julio Avila-Campos
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

5.  Effectiveness and safety of morinidazole in the treatment of pelvic inflammatory disease: A multicenter, prospective, open-label phase IV trial.

Authors:  Ting Zhou; Ming Yuan; Pengfei Cui; Jingjing Li; Feifei Jia; Shixuan Wang; Ronghua Liu
Journal:  Front Med (Lausanne)       Date:  2022-08-03

6.  Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.

Authors:  Wafaa Jamal; Fatima Bibi Khodakhast; Ameerah AlAzmi; Jόzsef Sόki; Ghayda AlHashem; Vincent O Rotimi
Journal:  BMC Microbiol       Date:  2020-01-15       Impact factor: 3.605

7.  In Vitro Efficacy of Antibiotic Combinations with Carbapenems and Other Agents against Anaerobic Bacteria.

Authors:  Takumi Umemura; Mao Hagihara; Takeshi Mori; Hiroshige Mikamo
Journal:  Antibiotics (Basel)       Date:  2022-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.